Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1996
08/28/1996EP0728005A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
08/28/1996EP0728000A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation
08/28/1996EP0727998A1 Oxazoles for treating cytokine mediated diseases
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/28/1996EP0727990A1 Compounds, compositions and treatment of allergies and inflammation
08/28/1996EP0727989A1 Butyric ester cyto-differentiating agents
08/28/1996EP0727986A1 Treatment of migraine
08/28/1996EP0727983A1 Process for preparing a clodronate preparation
08/28/1996EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth
08/28/1996EP0523100B1 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6 -alkylguanine-dna alkyltransferase depleting activity
08/28/1996EP0406297B1 Medical use of neuropeptide Antagonist G
08/28/1996EP0397697B1 Quinoline derivatives as antagonists of leukotriene d 4?
08/28/1996EP0313578B1 Novel osteoinductive compositions
08/28/1996CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity
08/28/1996CN1129940A Bicyclic tetrahydro pyrazolopyridines
08/28/1996CN1129938A Alkoxy-substituted beta-carbolines acting on the ampa-receptor
08/28/1996CN1129937A Indoline derivatives as 5HT2C antagonists
08/28/1996CN1129933A 5-arylindole derivatives
08/28/1996CN1129907A Inhibition of smooth muscle cell migration by (R)-amlodipine
08/28/1996CN1129702A Imidazopyridines
08/28/1996CN1129697A New 5-(aryloxymethyl) oxazolines, a process for the preparation thereof and pharmaceutical compositions containing them
08/28/1996CN1129589A Medicine for curing enuresis
08/27/1996US5550240 For inhibiting lipid peroxidation after brain or spinal column injuries
08/27/1996US5550188 Polymer conjugates ophthalmic devices comprising collagen-polymer conjugates
08/27/1996US5550165 Containing 4-hydroxyphenylpyruvate dioxygenase inhibiting amount of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
08/27/1996US5550151 Methods of reducing scarring in wound healing
08/27/1996US5550149 Sulfur-containing compounds that are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing sensitivity of multi-drug resistant cells
08/27/1996US5550142 Phenyl heterocycles as cox-2 inhibitors
08/27/1996US5550139 Serine protease inhibitors
08/27/1996US5550129 Benzopyranones, processes for their preparation and their use
08/27/1996US5550123 Methods for inhibiting bone prosthesis degeneration
08/27/1996US5550118 Polyhydronorharman synthase inhibitors
08/27/1996US5550107 Anticarcinogenic agents and antiestrogens
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025497A1 New chemokines expressed in pancreas
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025397A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996WO1996025392A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025166A1 Method of lessening the risk of vertebral fractures
08/22/1996WO1996025165A1 Method of lessening the risk of non-vertebral bone fractures
08/22/1996WO1996025143A1 Cosmetic or pharmaceutical, particularly dermatological, composition containing a bertholletia extract
08/22/1996WO1996017584A3 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
08/22/1996DE19506885A1 Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneolderivate, processes for their preparation and their pharmaceutical use
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2213211A1 New borneol derivatives, process for their production, and their pharmaceutical use
08/22/1996CA2213076A1 Method of lessening the risk of vertebral fractures
08/22/1996CA2212996A1 Method of lessening the risk of non-vertebral bone fractures
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211836A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0727211A1 Use of src SH2 specific compounds to treat a bone resorption disease
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726899A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
08/21/1996EP0726898A1 Phenylindole compounds
08/21/1996EP0726897A1 Process for the preparation of n-4- (substituted phenyl)alkylthienyl]-, and n-4- (substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726893A1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
08/21/1996EP0726892A1 (e)-20(22)-dehydrovitamin d compounds
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726766A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0584186B1 Receptor ligands
08/21/1996EP0584115B1 Medicaments containing azacyclodiphosphonic acid derivatives, novel azacyclodiphosphonic acid derivatives and process for producing them
08/21/1996EP0540614B1 3-(1-substitutedpyrazoyl)-2-oxindole derivatives
08/21/1996EP0512002B1 Cell-specific enzyme-conjugates for the release of toxic cyanide from cyanogenic prodrugs at target cells
08/21/1996EP0500844B1 Drug containing cd14
08/21/1996CN1129449A Heterocycles useful as neurokinin antagonists
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129443A Secondary amines as antidiabetic and antiobesity agents
08/21/1996CN1129440A Phenoxyphenyl cyclopentenyl hydroxyureas
08/21/1996CN1129219A Pharmaceutical compounds
08/21/1996CN1129216A Hydroxamic acid derivatives with tricylic substitution
08/21/1996CN1129128A Vitalizing health-care liquid
08/21/1996CN1129126A Tea of prolonging life
08/21/1996CN1129102A Catechol diether compounds as inhibitors of TNF release
08/20/1996US5548068 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
08/20/1996US5547971 Use of leflunomide for inhibiting interleukin 8
08/20/1996US5547970 Use of leflunomide for inhibiting tumor necrosis factor alpha
08/20/1996US5547968 Treatment of ocular hypertension with a synergistic combination
08/20/1996US5547964 Antiemetic during drug therapy
08/20/1996US5547963 Method for stimulating nerve regeneration
08/20/1996US5547959 For treatment of the autoimmune disease systemic lupus erythematosus
08/20/1996US5547958 Parkinson's disease
08/20/1996US5547940 Using a polypeptide
08/20/1996US5547938 Administering glicentin to inhibit peristalsis in stomach or duodenum
08/20/1996US5547856 Hepatocyte growth factor variants
08/20/1996CA2019324C Fosinopril tablet formulations
1 ... 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 ... 1564